about
Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare data.Intracranial hemorrhage in patients with brain metastases treated with therapeutic enoxaparin: a matched cohort study.Low-molecular-weight heparins and cancer: focus on antitumoral effect.Safety of anticoagulant treatment in cancer patients.Randomized phase III trial of low-molecular-weight heparin enoxaparin in addition to standard treatment in small-cell lung cancer: the RASTEN trial.Venous thromboembolism and mortality in breast cancer: cohort study with systematic review and meta-analysis.The GAG-specific branched peptide NT4 reduces angiogenesis and invasiveness of tumor cells.
P2860
Q31104892-BACC02EE-0FCC-4A2A-8B47-59B5FD1E73E1Q35994289-01D179A3-F16E-47C9-A8D6-333342823F9DQ38376242-5E349819-9F56-40D1-80B6-A7782B5AD313Q38523012-2438615F-63DC-43F9-93FA-EC46D2E72F49Q47177842-A9D72B34-6FB4-4526-B038-40D69E33213DQ47616727-55D2664E-ECE2-4B4D-A6E6-5FEC875A8D52Q55318767-B94B577A-8343-440C-B92B-17FD4D2D2A8E
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Heparins and cancer survival: where do we stand?
@en
type
label
Heparins and cancer survival: where do we stand?
@en
prefLabel
Heparins and cancer survival: where do we stand?
@en
P1433
P1476
Heparins and cancer survival: where do we stand?
@en
P2093
Simon Noble
P304
P356
10.1016/S0049-3848(14)50023-0
P478
133 Suppl 2
P50
P577
2014-05-01T00:00:00Z